nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—ALB—Acitretin—psoriasis	0.215	0.493	CbGbCtD
Sucralfate—ALB—Mycophenolate mofetil—psoriasis	0.101	0.231	CbGbCtD
Sucralfate—ALB—Prednisone—psoriasis	0.0803	0.184	CbGbCtD
Sucralfate—ALB—Methotrexate—psoriasis	0.0403	0.0925	CbGbCtD
Sucralfate—EGF—skin epidermis—psoriasis	0.0242	0.403	CbGeAlD
Sucralfate—EGF—endothelium—psoriasis	0.0176	0.293	CbGeAlD
Sucralfate—Haemolysis—Calcitriol—psoriasis	0.0161	0.152	CcSEcCtD
Sucralfate—EGF—skin of body—psoriasis	0.00751	0.125	CbGeAlD
Sucralfate—Haemolysis—Mycophenolate mofetil—psoriasis	0.00745	0.0703	CcSEcCtD
Sucralfate—EGF—tendon—psoriasis	0.00572	0.0951	CbGeAlD
Sucralfate—FGF2—tendon—psoriasis	0.00504	0.0839	CbGeAlD
Sucralfate—Fluid overload—Mycophenolic acid—psoriasis	0.00483	0.0456	CcSEcCtD
Sucralfate—Lung disorder—Mycophenolic acid—psoriasis	0.00424	0.04	CcSEcCtD
Sucralfate—Fluid overload—Mycophenolate mofetil—psoriasis	0.00381	0.0359	CcSEcCtD
Sucralfate—Oedema—Tazarotene—psoriasis	0.0034	0.0321	CcSEcCtD
Sucralfate—Lung disorder—Mycophenolate mofetil—psoriasis	0.00335	0.0316	CcSEcCtD
Sucralfate—Infection—Clobetasol propionate—psoriasis	0.00287	0.027	CcSEcCtD
Sucralfate—Infection—Beclomethasone—psoriasis	0.00261	0.0246	CcSEcCtD
Sucralfate—Infection—Fluocinonide—psoriasis	0.00258	0.0244	CcSEcCtD
Sucralfate—Phlebitis—Mycophenolic acid—psoriasis	0.00253	0.0239	CcSEcCtD
Sucralfate—Hyponatraemia—Mycophenolic acid—psoriasis	0.00219	0.0206	CcSEcCtD
Sucralfate—Extravasation—Dexamethasone—psoriasis	0.00211	0.0199	CcSEcCtD
Sucralfate—Extravasation—Betamethasone—psoriasis	0.00211	0.0199	CcSEcCtD
Sucralfate—Oedema—Methoxsalen—psoriasis	0.00205	0.0194	CcSEcCtD
Sucralfate—Infection—Methoxsalen—psoriasis	0.00204	0.0193	CcSEcCtD
Sucralfate—Phlebitis—Mycophenolate mofetil—psoriasis	0.002	0.0188	CcSEcCtD
Sucralfate—Lung disorder—Methotrexate—psoriasis	0.0019	0.0179	CcSEcCtD
Sucralfate—Hyponatraemia—Mycophenolate mofetil—psoriasis	0.00173	0.0163	CcSEcCtD
Sucralfate—Oedema—Acitretin—psoriasis	0.00163	0.0154	CcSEcCtD
Sucralfate—Oedema—Fluocinolone Acetonide—psoriasis	0.00162	0.0153	CcSEcCtD
Sucralfate—Body temperature increased—Methoxsalen—psoriasis	0.00162	0.0153	CcSEcCtD
Sucralfate—Infection—Acitretin—psoriasis	0.00162	0.0153	CcSEcCtD
Sucralfate—Infection—Fluocinolone Acetonide—psoriasis	0.00161	0.0152	CcSEcCtD
Sucralfate—Extravasation—Methotrexate—psoriasis	0.00154	0.0145	CcSEcCtD
Sucralfate—Body temperature increased—Calcitriol—psoriasis	0.00145	0.0137	CcSEcCtD
Sucralfate—Body temperature increased—Acitretin—psoriasis	0.00129	0.0121	CcSEcCtD
Sucralfate—Body temperature increased—Fluocinolone Acetonide—psoriasis	0.00128	0.0121	CcSEcCtD
Sucralfate—Oedema—Hydroxyurea—psoriasis	0.00128	0.0121	CcSEcCtD
Sucralfate—Infection—Hydroxyurea—psoriasis	0.00127	0.012	CcSEcCtD
Sucralfate—Oedema—Mycophenolic acid—psoriasis	0.00107	0.0101	CcSEcCtD
Sucralfate—Infection—Mycophenolic acid—psoriasis	0.00106	0.01	CcSEcCtD
Sucralfate—Body temperature increased—Hydroxyurea—psoriasis	0.00101	0.00954	CcSEcCtD
Sucralfate—Oedema—Cyclosporine—psoriasis	0.000866	0.00818	CcSEcCtD
Sucralfate—Infection—Cyclosporine—psoriasis	0.00086	0.00812	CcSEcCtD
Sucralfate—Body temperature increased—Mycophenolic acid—psoriasis	0.000846	0.00799	CcSEcCtD
Sucralfate—Oedema—Mycophenolate mofetil—psoriasis	0.000845	0.00798	CcSEcCtD
Sucralfate—Infection—Mycophenolate mofetil—psoriasis	0.000839	0.00792	CcSEcCtD
Sucralfate—Oedema—Prednisolone—psoriasis	0.000788	0.00744	CcSEcCtD
Sucralfate—Oedema—Hydrocortisone—psoriasis	0.00077	0.00727	CcSEcCtD
Sucralfate—Infection—Hydrocortisone—psoriasis	0.000765	0.00722	CcSEcCtD
Sucralfate—Oedema—Triamcinolone—psoriasis	0.000725	0.00684	CcSEcCtD
Sucralfate—Infection—Triamcinolone—psoriasis	0.00072	0.0068	CcSEcCtD
Sucralfate—Body temperature increased—Cyclosporine—psoriasis	0.000685	0.00646	CcSEcCtD
Sucralfate—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000668	0.0063	CcSEcCtD
Sucralfate—Oedema—Betamethasone—psoriasis	0.000658	0.00621	CcSEcCtD
Sucralfate—Oedema—Dexamethasone—psoriasis	0.000658	0.00621	CcSEcCtD
Sucralfate—Infection—Dexamethasone—psoriasis	0.000653	0.00617	CcSEcCtD
Sucralfate—Infection—Betamethasone—psoriasis	0.000653	0.00617	CcSEcCtD
Sucralfate—Body temperature increased—Hydrocortisone—psoriasis	0.000608	0.00574	CcSEcCtD
Sucralfate—Body temperature increased—Triamcinolone—psoriasis	0.000573	0.00541	CcSEcCtD
Sucralfate—Oedema—Prednisone—psoriasis	0.000573	0.00541	CcSEcCtD
Sucralfate—Infection—Prednisone—psoriasis	0.000569	0.00537	CcSEcCtD
Sucralfate—Body temperature increased—Betamethasone—psoriasis	0.00052	0.00491	CcSEcCtD
Sucralfate—Body temperature increased—Dexamethasone—psoriasis	0.00052	0.00491	CcSEcCtD
Sucralfate—Infection—Methotrexate—psoriasis	0.000475	0.00449	CcSEcCtD
Sucralfate—Body temperature increased—Prednisone—psoriasis	0.000453	0.00427	CcSEcCtD
Sucralfate—Body temperature increased—Methotrexate—psoriasis	0.000378	0.00357	CcSEcCtD
Sucralfate—FGF2—Signaling by NGF—NFKBIA—psoriasis	0.000286	0.000719	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR—IL6—psoriasis	0.000286	0.000717	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—HLA-A—psoriasis	0.000285	0.000716	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—HLA-E—psoriasis	0.000284	0.000714	CbGpPWpGaD
Sucralfate—FGF2—Insulin receptor signalling cascade—IL6—psoriasis	0.000284	0.000714	CbGpPWpGaD
Sucralfate—FGF2—IGF1R signaling cascade—IL6—psoriasis	0.000284	0.000714	CbGpPWpGaD
Sucralfate—EGF—Signaling by ERBB2—IL6—psoriasis	0.000284	0.000714	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—CRP—psoriasis	0.000283	0.000711	CbGpPWpGaD
Sucralfate—EGF—DAP12 signaling—IL6—psoriasis	0.000283	0.00071	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—psoriasis	0.000281	0.000706	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—JUN—psoriasis	0.000279	0.0007	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	0.000274	0.000687	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—HLA-E—psoriasis	0.000273	0.000686	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—VEGFA—psoriasis	0.000272	0.000682	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TAGAP—psoriasis	0.000271	0.000681	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	0.00027	0.000679	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—NFKB1—psoriasis	0.000268	0.000674	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR in disease—IL6—psoriasis	0.000266	0.000668	CbGpPWpGaD
Sucralfate—EGF—DAP12 interactions—IL6—psoriasis	0.000266	0.000668	CbGpPWpGaD
Sucralfate—EGF—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	0.000266	0.000668	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—VEGFA—psoriasis	0.000266	0.000668	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—VEGFA—psoriasis	0.000266	0.000668	CbGpPWpGaD
Sucralfate—ALB—SLC-mediated transmembrane transport—CP—psoriasis	0.000265	0.000666	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	0.000265	0.000665	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR—IL6—psoriasis	0.000264	0.000662	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	0.000262	0.000659	CbGpPWpGaD
Sucralfate—EGF—Immune System—HLA-E—psoriasis	0.000262	0.000657	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR in Cancer—IL6—psoriasis	0.000261	0.000656	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—HLA-DRB1—psoriasis	0.00026	0.000654	CbGpPWpGaD
Sucralfate—EGF—Signaling by PDGF—IL6—psoriasis	0.00026	0.000654	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—STAT3—psoriasis	0.00026	0.000653	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—STAT3—psoriasis	0.00026	0.000652	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—IFNG—psoriasis	0.000259	0.00065	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—NFKBIA—psoriasis	0.000258	0.000648	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCL20—psoriasis	0.000257	0.000645	CbGpPWpGaD
Sucralfate—FGA—Disease—HLA-A—psoriasis	0.000256	0.000642	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	0.000252	0.000634	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—ICAM1—psoriasis	0.00025	0.000627	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—NFKB1—psoriasis	0.000248	0.000624	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—NFKBIA—psoriasis	0.000248	0.000622	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—STAT3—psoriasis	0.000241	0.000606	CbGpPWpGaD
Sucralfate—FGA—Disease—APOE—psoriasis	0.000239	0.000599	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—SOCS1—psoriasis	0.000238	0.000597	CbGpPWpGaD
Sucralfate—FGF2—Signaling by Insulin receptor—IL6—psoriasis	0.000236	0.000593	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—STAT3—psoriasis	0.000236	0.000592	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	0.000236	0.000592	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—TYK2—psoriasis	0.000235	0.000589	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ITGAL—psoriasis	0.000232	0.000582	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—SOCS1—psoriasis	0.000231	0.000581	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	0.000229	0.000575	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—SOCS1—psoriasis	0.000228	0.000573	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—SOCS1—psoriasis	0.000226	0.000569	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—SOCS1—psoriasis	0.000226	0.000569	CbGpPWpGaD
Sucralfate—FGA—Disease—NOS2—psoriasis	0.000222	0.000559	CbGpPWpGaD
Sucralfate—EGF—Immune System—SOCS1—psoriasis	0.000219	0.000549	CbGpPWpGaD
Sucralfate—FGF2—Immune System—REL—psoriasis	0.000217	0.000545	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—NFKB1—psoriasis	0.000215	0.000541	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—STAT3—psoriasis	0.000214	0.000536	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—TYK2—psoriasis	0.000211	0.000531	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IFIH1—psoriasis	0.000211	0.000529	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—TNF—psoriasis	0.000206	0.000517	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—IFNG—psoriasis	0.000206	0.000516	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—TP53—psoriasis	0.000205	0.000515	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—HLA-B—psoriasis	0.000203	0.000509	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CD8A—psoriasis	0.000202	0.000508	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—IL6—psoriasis	0.000202	0.000507	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—TP53—psoriasis	0.000201	0.000505	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—TP53—psoriasis	0.000201	0.000505	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HLA-C—psoriasis	0.0002	0.000501	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—LEP—psoriasis	0.000198	0.000498	CbGpPWpGaD
Sucralfate—FGF2—Immune System—TNFAIP3—psoriasis	0.000197	0.000495	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	0.000196	0.000493	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—HLA-B—psoriasis	0.000195	0.000489	CbGpPWpGaD
Sucralfate—EGF—Immune System—CD8A—psoriasis	0.000194	0.000487	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—IL6—psoriasis	0.000193	0.000485	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—CD4—psoriasis	0.000191	0.00048	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—IL6—psoriasis	0.00019	0.000478	CbGpPWpGaD
Sucralfate—EGF—Immune System—HLA-B—psoriasis	0.000186	0.000468	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CD4—psoriasis	0.000184	0.000461	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—NFKB1—psoriasis	0.000183	0.000459	CbGpPWpGaD
Sucralfate—FGA—Disease—TYK2—psoriasis	0.000182	0.000457	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—IL6—psoriasis	0.000182	0.000456	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—IL6—psoriasis	0.000181	0.000455	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—IL6—psoriasis	0.000181	0.000454	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—HLA-A—psoriasis	0.00018	0.000453	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—IL6—psoriasis	0.00018	0.000452	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CRP—psoriasis	0.000179	0.00045	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—IL6—psoriasis	0.000179	0.00045	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	0.000173	0.000435	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—PPARG—psoriasis	0.000173	0.000434	CbGpPWpGaD
Sucralfate—EGF—Immune System—HLA-A—psoriasis	0.000173	0.000434	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—JUN—psoriasis	0.000171	0.00043	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	0.000171	0.00043	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—LEP—psoriasis	0.000171	0.000428	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—APOE—psoriasis	0.000171	0.000428	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	0.000168	0.000423	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—IL6—psoriasis	0.000168	0.000423	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—IL6—psoriasis	0.000168	0.000423	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—VEGFA—psoriasis	0.000168	0.000421	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TNF—psoriasis	0.000168	0.000421	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—LEP—psoriasis	0.000167	0.00042	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—APOE—psoriasis	0.000167	0.00042	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—APOE—psoriasis	0.000167	0.00042	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—LEP—psoriasis	0.000167	0.00042	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—IL6—psoriasis	0.000167	0.000419	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—IL6—psoriasis	0.000166	0.000417	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—VEGFA—psoriasis	0.000166	0.000417	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HLA-E—psoriasis	0.000166	0.000416	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—IL6—psoriasis	0.000165	0.000415	CbGpPWpGaD
Sucralfate—EGF—Immune System—CRP—psoriasis	0.000165	0.000414	CbGpPWpGaD
Sucralfate—FGA—Disease—CD4—psoriasis	0.000165	0.000414	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—HLA-DRB1—psoriasis	0.000165	0.000414	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—NFKB1—psoriasis	0.000165	0.000414	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—IL6—psoriasis	0.000165	0.000414	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—STAT3—psoriasis	0.000164	0.000412	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—NFKBIA—psoriasis	0.000163	0.00041	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCL20—psoriasis	0.000162	0.000408	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—ITGAL—psoriasis	0.000161	0.000405	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	0.00016	0.000401	CbGpPWpGaD
Sucralfate—EGF—Disease—HLA-A—psoriasis	0.00016	0.000401	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NFKBIA—psoriasis	0.000159	0.000399	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—NFKB1—psoriasis	0.000158	0.000397	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—ICAM1—psoriasis	0.000158	0.000397	CbGpPWpGaD
Sucralfate—EGF—Immune System—HLA-DRB1—psoriasis	0.000158	0.000396	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—NFKBIA—psoriasis	0.000157	0.000394	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NFKBIA—psoriasis	0.000156	0.000391	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NFKBIA—psoriasis	0.000156	0.000391	CbGpPWpGaD
Sucralfate—EGF—Immune System—ICAM1—psoriasis	0.000152	0.000381	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TYK2—psoriasis	0.000151	0.00038	CbGpPWpGaD
Sucralfate—EGF—Immune System—NFKBIA—psoriasis	0.00015	0.000378	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	0.000149	0.000375	CbGpPWpGaD
Sucralfate—EGF—Disease—APOE—psoriasis	0.000149	0.000374	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TP53—psoriasis	0.000148	0.000371	CbGpPWpGaD
Sucralfate—ALB—Metabolism—NDUFA5—psoriasis	0.000145	0.000364	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SOCS1—psoriasis	0.000141	0.000355	CbGpPWpGaD
Sucralfate—EGF—Disease—NOS2—psoriasis	0.000139	0.000349	CbGpPWpGaD
Sucralfate—FGF2—Immune System—SOCS1—psoriasis	0.000138	0.000347	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000135	0.00034	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—IL6—psoriasis	0.000135	0.00034	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—CP—psoriasis	0.000135	0.000339	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—TYK2—psoriasis	0.000134	0.000336	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—TNF—psoriasis	0.000133	0.000334	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TYK2—psoriasis	0.00013	0.000327	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	0.000129	0.000323	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TYK2—psoriasis	0.000128	0.00032	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TYK2—psoriasis	0.000128	0.00032	CbGpPWpGaD
Sucralfate—FGA—Disease—STAT3—psoriasis	0.000128	0.00032	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TP53—psoriasis	0.000125	0.000315	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP2S1—psoriasis	0.000123	0.00031	CbGpPWpGaD
Sucralfate—EGF—Immune System—TYK2—psoriasis	0.000123	0.000309	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD8A—psoriasis	0.000123	0.000308	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CD4—psoriasis	0.000121	0.000304	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—NFKB1—psoriasis	0.000118	0.000296	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HLA-B—psoriasis	0.000118	0.000296	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CD4—psoriasis	0.000116	0.000292	CbGpPWpGaD
Sucralfate—EGF—Immune System—IFNG—psoriasis	0.000115	0.00029	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—IL6—psoriasis	0.000115	0.000288	CbGpPWpGaD
Sucralfate—EGF—Disease—TYK2—psoriasis	0.000114	0.000286	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CXCL8—psoriasis	0.000113	0.000285	CbGpPWpGaD
Sucralfate—EGF—Immune System—CD4—psoriasis	0.000111	0.00028	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CXCL8—psoriasis	0.000111	0.000279	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CXCL8—psoriasis	0.000111	0.000279	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HLA-A—psoriasis	0.000109	0.000275	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—JUN—psoriasis	0.000108	0.000272	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—IL6—psoriasis	0.000107	0.00027	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—VEGFA—psoriasis	0.000107	0.000269	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—STAT3—psoriasis	0.000106	0.000266	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—JUN—psoriasis	0.000105	0.000265	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CRP—psoriasis	0.000104	0.000262	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—LEP—psoriasis	0.000104	0.000262	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—APOE—psoriasis	0.000104	0.000262	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—NFKB1—psoriasis	0.000104	0.000262	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—IL6—psoriasis	0.000103	0.00026	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—JUN—psoriasis	0.000103	0.000259	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—JUN—psoriasis	0.000103	0.000259	CbGpPWpGaD
Sucralfate—EGF—Disease—CD4—psoriasis	0.000103	0.000258	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NFKB1—psoriasis	0.000101	0.000255	CbGpPWpGaD
Sucralfate—FGF2—Disease—HLA-A—psoriasis	0.000101	0.000254	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—NFKB1—psoriasis	0.0001	0.000251	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HLA-DRB1—psoriasis	9.99e-05	0.000251	CbGpPWpGaD
Sucralfate—EGF—Immune System—JUN—psoriasis	9.97e-05	0.00025	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NFKB1—psoriasis	9.94e-05	0.00025	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NFKB1—psoriasis	9.94e-05	0.00025	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NFKBIA—psoriasis	9.72e-05	0.000244	CbGpPWpGaD
Sucralfate—EGF—Immune System—NFKB1—psoriasis	9.59e-05	0.000241	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ICAM1—psoriasis	9.59e-05	0.000241	CbGpPWpGaD
Sucralfate—FGF2—Immune System—NFKBIA—psoriasis	9.51e-05	0.000239	CbGpPWpGaD
Sucralfate—FGF2—Disease—APOE—psoriasis	9.43e-05	0.000237	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—VEGFA—psoriasis	9.21e-05	0.000231	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TNF—psoriasis	9.18e-05	0.000231	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—STAT3—psoriasis	9.12e-05	0.000229	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—VEGFA—psoriasis	9.02e-05	0.000227	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—VEGFA—psoriasis	9.02e-05	0.000227	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SOCS1—psoriasis	8.94e-05	0.000225	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—STAT3—psoriasis	8.93e-05	0.000224	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—STAT3—psoriasis	8.93e-05	0.000224	CbGpPWpGaD
Sucralfate—FGA—Disease—IL6—psoriasis	8.91e-05	0.000224	CbGpPWpGaD
Sucralfate—FGF2—Disease—NOS2—psoriasis	8.78e-05	0.000221	CbGpPWpGaD
Sucralfate—EGF—Immune System—STAT3—psoriasis	8.62e-05	0.000217	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TYK2—psoriasis	7.96e-05	0.0002	CbGpPWpGaD
Sucralfate—EGF—Disease—STAT3—psoriasis	7.96e-05	0.0002	CbGpPWpGaD
Sucralfate—FGF2—Immune System—TYK2—psoriasis	7.79e-05	0.000196	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	7.43e-05	0.000187	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—IL6—psoriasis	7.41e-05	0.000186	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IFNG—psoriasis	7.3e-05	0.000183	CbGpPWpGaD
Sucralfate—FGF2—Disease—TYK2—psoriasis	7.19e-05	0.000181	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD4—psoriasis	7.05e-05	0.000177	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TP53—psoriasis	6.96e-05	0.000175	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CXCL8—psoriasis	6.93e-05	0.000174	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TP53—psoriasis	6.82e-05	0.000171	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TP53—psoriasis	6.82e-05	0.000171	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—NOS2—psoriasis	6.62e-05	0.000166	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—APOE—psoriasis	6.6e-05	0.000166	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—LEP—psoriasis	6.6e-05	0.000166	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—IL6—psoriasis	6.54e-05	0.000164	CbGpPWpGaD
Sucralfate—FGF2—Disease—CD4—psoriasis	6.51e-05	0.000163	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.46e-05	0.000162	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—JUN—psoriasis	6.44e-05	0.000162	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IL6—psoriasis	6.37e-05	0.00016	CbGpPWpGaD
Sucralfate—FGF2—Immune System—JUN—psoriasis	6.31e-05	0.000158	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IL6—psoriasis	6.24e-05	0.000157	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IL6—psoriasis	6.24e-05	0.000157	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NFKB1—psoriasis	6.2e-05	0.000156	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NFKBIA—psoriasis	6.15e-05	0.000154	CbGpPWpGaD
Sucralfate—FGF2—Immune System—NFKB1—psoriasis	6.07e-05	0.000152	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CARM1—psoriasis	6.02e-05	0.000151	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL6—psoriasis	6.02e-05	0.000151	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.63e-05	0.000141	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—VEGFA—psoriasis	5.63e-05	0.000141	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—STAT3—psoriasis	5.57e-05	0.00014	CbGpPWpGaD
Sucralfate—EGF—Disease—IL6—psoriasis	5.56e-05	0.00014	CbGpPWpGaD
Sucralfate—FGF2—Immune System—STAT3—psoriasis	5.46e-05	0.000137	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TYK2—psoriasis	5.04e-05	0.000127	CbGpPWpGaD
Sucralfate—FGF2—Disease—STAT3—psoriasis	5.04e-05	0.000127	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CXCL8—psoriasis	4.39e-05	0.00011	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TP53—psoriasis	4.25e-05	0.000107	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—JUN—psoriasis	4.08e-05	0.000102	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NFKB1—psoriasis	3.93e-05	9.86e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IL6—psoriasis	3.89e-05	9.78e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—VEGFA—psoriasis	3.83e-05	9.62e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL6—psoriasis	3.81e-05	9.57e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CAT—psoriasis	3.7e-05	9.3e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—VEGFA—psoriasis	3.56e-05	8.95e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—STAT3—psoriasis	3.53e-05	8.86e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—IL6—psoriasis	3.52e-05	8.84e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TP53—psoriasis	2.9e-05	7.27e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APOE—psoriasis	2.88e-05	7.23e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TP53—psoriasis	2.69e-05	6.76e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PPARG—psoriasis	2.51e-05	6.3e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL6—psoriasis	2.46e-05	6.19e-05	CbGpPWpGaD
